Chembio Diagnostics (CEMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2007 | 12-2006 | 12-2005 | 12-2004 | 12-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,627 | -4,995 | -3,252 | -3,099 | -1,060 |
| Depreciation Amortization | 283 | 210 | 99 | 110 | 134 |
| Accounts receivable | 437 | -118 | -1,094 | 119 | -151 |
| Other Working Capital | 676 | -433 | -934 | -298 | 480 |
| Other Operating Activity | -116 | 1,134 | 1,176 | 520 | 172 |
| Operating Cash Flow | $-1,346 | $-4,203 | $-4,005 | $-2,648 | $-424 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -410 | -375 | -349 | -61 | N/A |
| Investing Cash Flow | $-410 | $-375 | $-349 | $-61 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,300 | 162 | 295 | N/A |
| Debt Repayment | -52 | -38 | -43 | -123 | 31 |
| Common Stock Issued | 559 | 146 | 25 | 361 | N/A |
| Dividend Paid | -120 | -200 | N/A | N/A | N/A |
| Other Financing Activity | -93 | 7,428 | 4,407 | 2,210 | 365 |
| Financing Cash Flow | $293 | $8,636 | $4,551 | $2,743 | $396 |
| Beginning Cash Position | 4,290 | 232 | 35 | N/A | 28 |
| End Cash Position | 2,827 | 4,290 | 232 | 35 | N/A |
| Net Cash Flow | $-1,463 | $4,058 | $197 | $35 | $-28 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,346 | -4,203 | -4,005 | -2,648 | -424 |
| Capital Expenditure | -410 | -375 | -349 | -61 | N/A |
| Free Cash Flow | -1,756 | -4,577 | -4,354 | -2,708 | -424 |